Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors

Overview of attention for article published in PLOS ONE, February 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 1 X user

patent: 8 patents

Readers on

mendeley: 35 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Viral vector constructs for expression of genetic adjuvants activating the CD40 and STING…

Grant US-11674153-B2

United States of America

13 Jun 2023

Viral vector constructs for expression of genetic adjuvants activating the STING pathway

Grant US-11638752-B2

United States of America

02 May 2023

Modified EC7 cells having low toxicity to viral production payloads

Grant US-11485957-B2

United States of America

01 Nov 2022

Goose source mitochondria antiviral signal protein and application thereof

Grant CN-108329386-B

China

03 Aug 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.